Dizziness, fatigue, brain fog and a racing heart. They're commonly associated with Long COVID, but new Adelaide University ...

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) reported topline results from its Phase 2 ADDRESS-LC trial evaluating bezisterim, an oral investigational drug for Long COVID, showing statistically significant ...

Researchers are studying the curious connection between autoimmune diseases and conditions like POTS and long COVID—in the ...

A national RECOVER cohort reveals why Long COVID doesn’t follow a single recovery pattern. Instead, it shows who stays sick, who improves, and who unexpectedly worsens as symptoms evolve long after ...

Nirmatrelvir-ritonavir (Paxlovid) wasn't any more effective at relieving long COVID symptoms than placebo, according to a ...

Results from a clinical trial and published today in the journal Lancet Infectious Diseases show that the antiviral drug ...

Attention has waned but patients are still suffering ...

Scientists found up to 20% less dopamine nerve density in long COVID patients, and say the damage tracks closely with ...

Add Yahoo as a preferred source to see more of our stories on Google. Millions of people are experiencing a post-COVID illness known as long COVID. The coronavirus pandemic looks a lot different from ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

A Lancet model says confidential drugmaker deals could erase 71% to nearly 80% of projected Medicare savings from foreign drug price benchmarks. Many insurance denials are reversed on appeal, but odds ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. It's been more than five years since the start of the COVID-19 pandemic ...